• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

First Tracks Biotherapeutics, Inc. - Ordinary Shares (NQ:TRAX)

34.05 +2.20 (+6.91%)
Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,306,059
Open 39.45
Bid (Size) 32.98 (300)
Ask (Size) 34.00 (1,500)
Prev. Close 31.85
Today's Range 33.02 - 40.50
52wk Range 14.72 - 49.91
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
First Tracks’ ANB033 Clears Key Phase Ib Celiac Disease Study Goals ↗
Today 13:02 EDT
First Tracks Biotherapeutics (NASDAQ:TRAX) reported top-line results from the first cohort of its Phase Ib study of ANB033 in celiac disease, saying the investigational CD122 antagonist met histologic... 
Via MarketBeat
These stocks are gapping in today's session ↗
Today 10:30 EDT
Via Chartmill

Performance

52-Week Range 31.8% below 52-week high
34.05
14.7252W Low 49.9152W High
1 Week 1.1% below 1-week high
30.111W Low 34.441W High

First Tracks Biotherapeutics, Inc. - Ordinary Shares (TRAX) traded between $14.72 and $49.91 over the past 52 weeks and last traded at $34.05, 31.8% below its 52-week high. Over the past week it ranged between $30.11 and $34.44.

Past 12 Months
+3.2%
-6.6%
-2.7%
+83.1%
+83.1%
+83.1%
1W +$1.06
1M -$2.39
3M -$0.96
6M +$15.45
YTD +$15.45
1Y +$15.45

TRAX was +83.1% over the past year, +83.1% over six months, +83.1% year to date, +3.2% in the last week.

12 Months vs Market
TRAX
+83.1%
DIA
+12.4%
SPY
+17.4%
QQQ
+23.9%
IWM
+13.7%

Over the past 12 months TRAX returned +83.1% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 10.10× 3-mo avg
Today 7,306,059 3-mo avg 723.5K
1W
795.2K
1M
798.7K
3M
723.5K
6M
701.6K
YTD
701.6K
1Y
701.6K

TRAX most recently traded 7,306,059 shares against a 3-month average daily volume of 723.5K.

More News

Read More
These stocks are moving in today's pre-market session ↗
Today 8:30 EDT
Via Chartmill
News headline image
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
Today 7:00 EDT
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
October 11, 2026
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
Which stocks are gapping on Wednesday? ↗
September 02, 2026
Via Chartmill
News headline image
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
August 26, 2026
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
July 27, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Monday. ↗
July 27, 2026
Via Chartmill
Which stocks are moving before the opening bell on Thursday? ↗
July 23, 2026
Via Chartmill
Which stocks are experiencing notable movement on Thursday? ↗
July 09, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
July 09, 2026
Via Chartmill
News headline image
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
May 21, 2026
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From First Tracks Biotherapeutics Inc
Via GlobeNewswire

Frequently Asked Questions

Is First Tracks Biotherapeutics, Inc. - Ordinary Shares publicly traded?
Yes, First Tracks Biotherapeutics, Inc. - Ordinary Shares is publicly traded.
What exchange does First Tracks Biotherapeutics, Inc. - Ordinary Shares trade on?
First Tracks Biotherapeutics, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for First Tracks Biotherapeutics, Inc. - Ordinary Shares?
The ticker symbol for First Tracks Biotherapeutics, Inc. - Ordinary Shares is TRAX on the Nasdaq Stock Market
What is the current price of First Tracks Biotherapeutics, Inc. - Ordinary Shares?
The current price of First Tracks Biotherapeutics, Inc. - Ordinary Shares is 34.05
When was First Tracks Biotherapeutics, Inc. - Ordinary Shares last traded?
The last trade of First Tracks Biotherapeutics, Inc. - Ordinary Shares was at 10/12/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap